KeyBanc Maintains Overweight Rating on HCA Healthcare, $490 Target
KeyBanc maintained its Overweight rating on HCA Healthcare and a $490 price target. The target implies 8.9% upside from the Oct. 27 close of $449.96.
KeyBanc maintained its Overweight rating on HCA Healthcare and a $490 price target. The target implies 8.9% upside from the Oct. 27 close of $449.96.